Aptivus (tipranavir oral solution, from Boehringer Ingelheim) has been approved for use in combination with ritonavir for treatment-experienced adults and pediatric patients 2-18 years of age infected with HIV-1.

Aptivus 100mg/mL oral solution is expected to be available in mid-September 2008. Aptivus 250mg capsules are already available for use with ritonavir in HIV-1 infection in highly treatment-experienced adults or in those with HIV strains resistant to multiple protease inhibitors.

For more information call (800) 243-0127 or visit www.aptivus.com.